Delivery Order SPE2DB20D1109-SPE2DB24FN77V
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order for 4563523858 - INGREZZA 40 MG CAPSULE 30S. The $3,119.55 contract has a completion date of February 26, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver this pharmaceutical product from its facility in Conshohocken, Pennsylvania. This order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product INGREZZA 80 MG CAPSULE 30S. The contract has a ceiling value of $3,893.15 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any specific business type. The company also holds...
- The Defense Logistics Agency (DLA) awarded a $3,119.55 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide INGREZZA 40 MG CAPSULE 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564249207 - INGREZZA 60 MG CAPSULE 30S. The contract has a ceiling value of $16,840.20 and a period of performance through May 2, 2024. This award is a child contract under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA to deliver pharmaceutical products...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $7,106.64 firm-fixed-price delivery order contract (SPE2DX15D3012|SPE2DX25F8DA2) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,566,078,085 units of the pharmaceutical product INGREZZA 40 MG CAPSULE 30S, with a period of performance ending on November 1, 2024. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,027.70 firm fixed-price delivery order is for the supply of INGREZZA 80 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of March 12, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical sourcing and distribution company. The contract is for the supply of INGREZZA 40 MG CAPSULE 30S, a specialty pharmaceutical product, with a potential value of $3,553.31 and a completion date of March 25, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded...
- This is a $4,027.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INGREZZA 80 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through July 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide INGREZZA 80 MG CAPSULE 30S, a pharmaceutical product, with a potential value of $3,893.15 and a completion date of March 12, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA with a potential value of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INGREZZA 80 MG CAPSULE 30S. The order has a firm fixed price of $3,714.98 and a completion date of February 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FN77VDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563920336 - INGREZZA 80 MG CAPSULE 30S. This $3,893.15 order, awarded on March 11, 2024, has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is the sole awardee on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen Drug Corp also holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to provide a broad range of pharmaceutical products and medical supplies to support Department of Defense medical treatment programs and facilities worldwide. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver these critical healthcare materials to DLA Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 3/11/24 |